As next year's epic soccer event approaches and fan excitement and travel prices soar,Outdoorsy, the world's largest RV rental and outdoor travel platform, is launching the Outdoorsy RV Roadtrip Concierge and delivering the definitive fan solution: the mobile RV homebase for devotees looking to follow their team and explore the US next summer. https://mma.prnewswire.com/media/2805079/Outdoorsy.jpg An […]

(CNSX:ROBO.CN),(Boerse Frankfurt – Freiverkehr:0XM1),(Pinksheets:TRMNF),(PinkSheets:TRMNF),(Pinksheets:RBOHF),(PinkSheets:RBOHF), Vancouver, BC, Oct. 27, 2025 (GLOBE NEWSWIRE) — Humanoid Global Holdings Corp. (“Humanoid Global” or the “Company“) (CSE:ROBO, FWB:0XM1, OTCQB:RBOHF), a publicly traded investment issuer focused on building and accelerating a portfolio of pioneering companies in the humanoid robotics and embodied AI sector, is pleased to announce that Saman Farid has

(TSX-V:RKV),(Boerse Frankfurt – Freiverkehr:7JO0), VANCOUVER, British Columbia, Oct. 27, 2025 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV)(FSE: 7JO0) is pleased to announce the successful presentation of new data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held October 23-27 in Boston, Massachusetts. The Company's poster, titled “Novel

Humanoid Global Welcomes Saman Farid to its Investment Advisory Board – NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES – GlobeNewswire October 27, 2025 Vancouver, BC, Oct. 27, 2025 (GLOBE NEWSWIRE) — Humanoid Global Holdings Corp. (“Humanoid Global” or the “Company“) (CSE:ROBO, FWB:0XM1, OTCQB:RBOHF), a publicly traded investment issuer focused on

Rakovina Therapeutics Showcases Potent AI-Developed ATR Inhibitors with CNS Penetrance at AACR-NCI-EORTC International Conference GlobeNewswire October 27, 2025 VANCOUVER, British Columbia, Oct. 27, 2025 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV)(FSE: 7JO0) is pleased to announce the successful presentation of new data at the AACR-NCI-EORTC International Conference on Molecular Targets

The DJS Law Group reminds investors of a class action lawsuit against Jasper Therapeutics, Inc. (“Jasper” or “the Company”) (NASDAQ: JSPR ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of JSPR during the

The DJS Law Group reminds investors of a class action lawsuit against Quanex Building Products Corporation (“Quanex ” or “the Company”) (NYSE: NX ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of NX

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit againstQuanex Building Products Corporation (“Quanex” or “the Company”) (NYSE: NX) forviolations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. https://mma.prnewswire.com/media/1396534/Schall_Firm_Logo.jpg Investors who purchased

The DJS Law Groupannounces that it is investigating claims on behalf of investors ofaTyr Pharma, Inc. (“aTyr” or “the Company”) (NASDAQ: ATYR) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statements and/or failed to disclose information pertinent to investors. On September 15, 2025, Reuters reported that,

EVANSVILLE, Ind., Oct. 27, 2025 (GLOBE NEWSWIRE) — When should someone consider therapy services, and how do they know which type of therapy is best? That question is answered in a HelloNation article featuring Rehabilitation Expert Kelly Schneider of Easterseals Rehabilitation Center in Evansville, Indiana. The feature explains the different forms of therapy available, how